Biologic drugs in the treatment of chronic inflammatory pulmonary diseases: recent developments and future perspectives.

Plichta, Jacek; Kuna, Piotr; Panek, Michal

Plichta, Jacek; Kuna, Piotr; Panek, Michal.

Affiliation

Plichta J; Department of Internal Medicine, Asthma and Allergy, Medical University of Lodz, Lodz, Poland.
Kuna P; Department of Internal Medicine, Asthma and Allergy, Medical University of Lodz, Lodz, Poland.
Panek M; Department of Internal Medicine, Asthma and Allergy, Medical University of Lodz, Lodz, Poland.

Front Immunol ; 14: 1207641, 2023.

Article in En | MEDLINE | ID: mdl-37334374

Subject(s)

Biological Products; Pulmonary Disease, Chronic Obstructive; Humans; Biological Products/therapeutic use; Administration, Inhalation; Pulmonary Disease, Chronic Obstructive/drug therapy; Chronic Disease; Lung; Antibodies, Monoclonal/therapeutic use

Key words

COPD; IPF; asthma; biologic drugs; monoclonal antibodies; pulmonary sarcoidosis

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biological Products / Pulmonary Disease, Chronic Obstructive Type of study: Clinical_trials Limits: Humans Language: En Journal: Front Immunol Year: 2023 Document type: Article Affiliation country: Poland Country of publication: Switzerland

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google